Scheherazade Sadegh-Nasseri

Scheherazade Sadegh-Nasseri

Auto-generated profile, based on publicly available information

Scheherazade Sadegh-Nasseri

Johns Hopkins University School of Medicine

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1991 in Nature
Verified
Journal Article
Closed access
PDF file
SSScheherazade Sadegh-Nasseri
Scheherazade Sadegh-Nasseri
RGRonald N. Germain
Ronald N. Germain

1 August 1987 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
GGGuy Gammon
Guy Gammon
NSNilabh Shastri
Nilabh Shastri
JCJohn Cogswell
John Cogswell
SWStanley Wilbltr
Stanley Wilbltr
SSScheherazade Sadegh‐Nasseri
Scheherazade Sadegh‐Nasseri
ESEli Sercarz
Eli Sercarz

1 August 1994 in Nature
Verified
Journal Article
Closed access
SSScheherazade Sadegh-Nasseri
Scheherazade Sadegh-Nasseri
LSLawrence J. Stern
Lawrence J. Stern
DWDon C. Wiley
Don C. Wiley
RGRonald N. Germain
Ronald N. Germain

11 December 2000 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CCChih-Ling Chou
Chih-Ling Chou
SSScheherazade Sadegh-Nasseri
Scheherazade Sadegh-Nasseri
DM facilitates formation of high affinity complexes of peptide–major histocompatibility complex (MHC) by release of class II MHC–associated invariant chain peptide (CLIP). This has been proposed to occur through discrimination of complex stability. By probing kinetic and conformational intermediates of the wild-type and mutant human histocompatibility leukocyte antigen (HLA)-DR1–peptide complexes, and examining their reactivities with DM, we propose that DM interacts with the flexible hydrophobic pocket 1 of DR1 and converts the molecule into a conformation that is highly peptide receptive. A more rigid conformation, generated upon filling of pocket 1, is less susceptible to DM effects. Thus, DM edits peptide–MHC by recognition of the flexibility rather than stability of the complex.

15 January 1993 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
WBW H Boehncke
W H Boehncke
TTT Takeshita
T Takeshita
CPC D Pendleton
C D Pendleton
RHR A Houghten
R A Houghten
SSS Sadegh-Nasseri
S Sadegh-Nasseri
RGR N Germain
R N Germain
Previous studies on the role of specific residues of the peptide or MHC molecule in Ag presentation have revealed the sensitivity of this complex system to even small changes in structure. In our study, we have analyzed the effect of amino acid substitution in a major CD4+ T cell determinant (T1) of HIV-1 gp160 on binding and recognition in the context of various E alpha E beta MHC class II molecules. Individual alanine substitutions at all but three positions had little or no negative effect on either MHC binding or recognition by a specific T hybridoma, whereas substitutions with larger side chains often diminished reactivity. A poly-alanine peptide containing only four of the original residues was an effective MHC class II binder and in vivo immunogen, although lacking the ability to stimulate the hybridoma. Replacement of a glutamic acid in T1 with alanine or a size-conservative, uncharged glutamine, but not a negatively charged aspartic acid produced a peptide at least 100-fold more potent than the parent peptide, indicating an inhibitory effect of the negative charge. Conversely, substitution of a glutamic acid for valine at position 29 in the floor of the peptide binding site of the E alpha E beta molecule decreased functional presentation of this peptide by more than 2 logs. However, these two effects of glutamic acid were not complementary and were mediated by distinct mechanisms, as the change in the peptide altered the extent of binding to class II, but the change in the MHC molecule decreased recognition without inhibiting peptide binding. Taken together, the data all suggest the conclusion that changes in side-chains of peptides and MHC molecules affect Ag presentation and T cell stimulation most often by introducing dominant negative or interfering groups that prevent or alter the pattern of binding events primarily mediated by a very limited number of other residues in the Ag or presenting molecule. These results have important implications for understanding the biochemistry of peptide-MHC-TCR interactions and for the possible design of vaccines both more potent and less subject to allele-specific limitations on immunogenicity.

1 June 1996 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
RGRonald N. Germain
Ronald N. Germain
FCFlora Castellino
Flora Castellino
RHRicai Han
Ricai Han
CSCaetano Reis E Sousa
Caetano Reis E Sousa
PRPaola Romagnoli
Paola Romagnoli
GZGuang‐Ming Zhunc
Guang‐Ming Zhunc